Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 64 for “"Progressive Supranuclear Palsy"”.
-
Perk Genetic Variation and Function in Progressive Supranuclear Palsy
Progressive supranuclear palsy (PSP) is a neurodegenerative disorder pathologically characterized by intracellular tangles of hyperphosphorylated tau protein distributed throughout the neocortex, basal ganglia, and brainstem. A genome-wide association study identified EIF2AK3 as a risk factor for …
-
Developing a Pre-Clinical Animal Model for Progressive Supranuclear Palsy
Progressive Supranuclear Palsy (PSP) is a classic Parkinsonian disease that is most commonly misdiagnosed as Parkinson’s. The distinguishing factor between Parkinson’s and PSP is the aggregation of a protein- tau, in different regions of the brain. The lack of accurate preclinical animal models is …
-
Progress towards the First Preclinical Model of Progressive Supranuclear Palsy (PSP)
Progressive Supranuclear Palsy (PSP) is a 4-repeat tauopathy characterized by early postural instability, vertical gaze palsy, cognitive decline, and widespread tau pathology affecting both motor and cognitive brain regions. Emerging evidence suggests that degeneration of the pedunculopontine …
-
Evaluating the Neuropathology of a Rat Model of Progressive Supranuclear Palsy
Progressive Supranuclear Palsy (PSP) is the most common atypical parkinsonism. Symptoms of this fatal neurodegenerative disease include motor impairment, postural instability, acoustic startle reflex deficits, and speech problems. Cognitive symptoms such as dementia, apathy, depression, and anxiety …
-
Mechanisms of synapse loss and tau propagation in progressive supranuclear palsy
In the neurodegenerative disease, Progressive Supranuclear Palsy (PSP) tau pathology progresses through the brain in a stereotypical spatiotemporal pattern, and where tau pathology appears, synapses are lost. We tested the hypotheses that pathological tau and glia directly contribute to synapse …
-
Characterisation of cortical pathology and clinicopathological correlates in progressive supranuclear palsy
… the cortical pattern of degeneration in progressive supranuclear palsy (PSP) and its consequences. Global atrophy was first examined using a recently developed staging scheme in pathologically-proven PSP cases compared with other tauopathies: gross atrophy was not observed in PSP. …
-
The effectiveness of allied health therapy in the symptomatic management of progressive supranuclear palsy: a systematic review
Background: Progressive supranuclear palsy is an adult onset neurodegenerative condition. Progressive supranuclear palsy is an aggressive condition associated with a continual loss of function and commonly, death due to aspiration pneumonia. Currently there is no cure, and dopaminergic medications …
-
Automatic Classification of Idiopathic Parkinsonian Disease and Progressive Supranuclear Palsy using Multi-Spectral MRI Datasets: A Machine Learning Approach
… atypical Parkinsonian syndromes (APS), such as progressive supranuclear palsy Richardson’s syndrome (PSP-RS). The differential diagnosis between PD and PSP-RS is often challenged by similarity of early symptoms, effectively resulting in considerable misclassification rates. The aim of this …
-
Characterization of synaptic and epigenetic alterations in the context of the astrocytic pathology in progressive Supranuclear Palsy and Corticobasal Degeneration
… significant contributions by astrocytes such as Progressive Supranuclear Palsy (PSP) and Corticobasal Degeneration (CBD). However, their molecular pathogenesis remains insuf-ficiently understood. This work is dedicated to the investigation of astrocytes in PSP and CBD. In the first project, …
-
Natural Anti-Tau Autoantibodies in Health and Disease
… diseases such as Alzheimer’s disease, progressive supranuclear palsy, corticobasal degeneration and frontotemporal dementia. In line with this, anti-tau immunotherapy strategies have emerged as a line of investigation with the goal of clearing pathology and improving function in …
-
THE GENETIC OVERLAP BETWEEN NEUROPSYCHIATRIC DISORDERS: A META-ANALYSIS OF NEXT GENERATION SEQUENCING DATA
… disease (AD), Parkinson’s disease (PD), Progressive Supranuclear Palsy (PSP), Pathological Aging (PA), Autism Spectrum Disorder (ASD), Schizophrenia (SZ), Major Depressive Disorder (MDD), and Bipolar Disorder (BP)-in comparison with 2,078 brain samples from matched control subjects. In …
-
Modeling tauopathies in vitro with diverse aggregation inducing techniques
… chronic traumatic encephalopathy, and progressive supranuclear palsy, tau has been found to dissociate from microtubules leading to the formation of pathological aggregates that display an amyloid fibril-like structure. Recent structural studies have shown that the tau filaments …
-
The Role Of Tau Strains In Generating The Diversity Of Human Tauopathies
… like corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP), tau inclusions are the most prominent neuropathological feature, solely contributing to the clinical symptoms and disease progression in those patients. Yet, tauopathies are highly diverse, with distinct …
-
Neural Correlates of Parkinsonian Syndromes
… patterns in Parkinson’s disease and progressive supranuclear palsy, we conducted meta-analyses. In Parkinson’s disease glucose hypometabolism was re- vealed in bilateral inferior parietal cortex and left caudate nucleus and focal gray matter atrophy in the middle occipital gyrus. In …
-
Characterization of Tau Oligomeric Strains: Implications for Disease Phenotypes
… I found that toxic tau oligomers are elevated in progressive supranuclear palsy, traumatic brain injury and synucleinopathy models and reversal of toxicity can be achieved with treatment of a tau oligomer-specific monoclonal antibody. Tau oligomers have prion-like properties, enabling them to seed …
-
The role of demographic, genetic and environmental factors in DNA methylation of microtubule-associated protein tau (MAPT) and their implications for neurodegenerative disease.
Neurodegenerative diseases involve the progressive damage or death of neurons leading to a range of symptoms that can include cognitive deficits, behavioural changes and movement difficulties. Idiopathic neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, are complex disorders …
-
RNA Drives Pathogenicity and Diversity of Tau Strains
… sensitive to RNase and not DNase. Tau seeds from progressive supranuclear palsy and corticobasal degeneration were sensitive to benzonase, a nuclease that indiscriminately digests DNA and RNA. Thus, RNA specifically induces stable tau strains, and may trigger the formation of dominant pathological …
-
Neurodegenerative Proteinopathy-Specific Dysregulation of Iron Homeostasis in the Human Brain
Progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are neurodegenerative diseases involving distinct protein pathology but are commonly characterized by pronounced iron deposition in vulnerable brain regions early affected in the disease-course. Neurotoxic iron burden has been …
Page 1 of 4